Odne Revolutionizes Root Canal Therapy with $5.5M Funding Boost

Odne, a Swiss dental startup, secures $5.5M in Series A1 funding to launch innovative root canal technology in the US market. Led by CEO Dr. Andreas Schmocker, Odne's advanced technology promises safer and faster root canal treatments with hydro-dynamic cavitation devices and FDA-cleared obturation materials. The investment from Revere Partner and NV Capital will drive Odne's mission to transform endodontics and improve patient outcomes. With over 60 million root canal treatments performed annually worldwide, Odne's breakthrough solutions aim to address the challenges faced by dentists and revolutionize the way root canal therapy is conducted. Get ready for a new era in dental care with Odne's cutting-edge technology.